Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | RPRX | BNTX | ||
| Company | Biogen Inc | Royalty Pharma Plc Cl A | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 178.82 | 48.50 | 99.74 | ||
| High | 179.99 | 48.97 | 102.15 | ||
| Low | 174.85 | 48.23 | 98.84 | ||
| Latest | 176.02 | 48.48 | 102.12 | ||
| Change | -4.52 | -0.22 | +2.65 | ||
| % Change | -2.50% | -0.45% | +2.66% | ||
| Volume | 953,514 | 2,107,807 | 647,022 | ||
| 20-Day Average Volume | 1,314,386 | 3,113,415 | 873,541 | ||
| Previous Close | 180.54 | 48.70 | 99.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 180.92 | 47.33 | 91.38 | ||
| 20-Day Raw Stochastic | 31.22% | 86.61% | 99.80% | ||
| 20-Day Relative Strength | 45.26 | 61.28 | 58.36 | ||
| Weighted Alpha | +41.57 | +52.59 | +2.19 | ||
| Today's Opinion | 8% Buy | 100% Buy | 24% Sell | ||
| Previous Opinion | 8% Buy | 100% Buy | 64% Sell | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.62% since 04/09/26 | +0.37% since 04/09/26 | +11.02% since 04/09/26 | ||
| Low | 171.22 on 04/13/26 | 47.73 on 04/10/26 | 92.29 on 04/10/26 | ||
| High | 181.77 on 04/14/26 | 49.01 on 04/14/26 | 102.15 on 04/16/26 | ||
| 1-Month | |||||
| %Chg | -3.95% since 03/16/26 | +5.16% since 03/16/26 | +12.79% since 03/16/26 | ||
| Low | 168.64 on 04/06/26 | 44.73 on 03/20/26 | 84.78 on 03/30/26 | ||
| High | 192.27 on 03/26/26 | 49.06 on 04/02/26 | 102.15 on 04/16/26 | ||
| 3-Month | |||||
| %Chg | +7.06% since 01/16/26 | +22.58% since 01/16/26 | -6.31% since 01/16/26 | ||
| Low | 160.36 on 01/20/26 | 38.86 on 01/20/26 | 79.52 on 03/10/26 | ||
| High | 202.41 on 02/06/26 | 49.06 on 04/02/26 | 124.00 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +23.73% since 10/16/25 | +33.41% since 10/16/25 | -2.82% since 10/16/25 | ||
| Low | 138.00 on 10/30/25 | 35.92 on 10/28/25 | 79.52 on 03/10/26 | ||
| High | 202.41 on 02/06/26 | 49.06 on 04/02/26 | 124.00 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,495,870 | 28,092,936 | 25,154,372 | ||
| Shares Outstanding, K | 146,759 | 576,857 | 252,884 | ||
| Annual Sales | 9,890,600,000 | 2,378,190,000 | 3,247,010,000 | ||
| Annual Net Income | 1,292,900,000 | 770,950,000 | -1,285,380,000 | ||
| Last Quarter Sales | 2,279,400,000 | 621,990,000 | 982,920,000 | ||
| Last Quarter Net Income | -48,900,000 | 214,210,000 | -374,920,000 | ||
| 60-Month Beta | 0.16 | 0.39 | 1.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 02/06/26 | 1.46 on 02/11/26 | -0.38 on 03/10/26 | ||
| Latest Earnings Date | 05/07/26 | 05/14/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | 0.235 on 02/20/26 | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 11.70 | 10.11 | 0.00 | ||